OPEN END-TURBO-OPTIONSSCHEIN - THERMO FISHER SCIENTIFIC Share Price

Certificat

DE000TT8XRZ1

Market Closed - BOERSE MUENCHEN 01:07:16 01/06/2024 am IST
14.67 EUR -1.68% Intraday chart for OPEN END-TURBO-OPTIONSSCHEIN - THERMO FISHER SCIENTIFIC
1 month+4.41%
3 months+8.03%
Date Price Change
31/24/31 14.67 -1.68%
30/24/30 14.92 +5.29%
29/24/29 14.17 +1.50%
28/24/28 13.96 +8.22%
27/24/27 12.9 -.--%

Real-time BOERSE MUENCHEN

Last update May 01, 2024 at 01:07 am IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying THERMO FISHER SCIENTIFIC
Issuer HSBC
WKN TT8XRZ
ISINDE000TT8XRZ1
Date issued 20/09/2021
Strike 721.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 15.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 27.73
Lowest since issue 5

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Sector
-
More about the company

Ratings for Thermo Fisher Scientific

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Thermo Fisher Scientific

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
568 USD
Average target price
627.5 USD
Spread / Average Target
+10.47%
Consensus